Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy? Source: Eur Respir J 2010; 35: 223-224 Year: 2010
Screening for pulmonary arterial hypertension in systemic sclerosis Source: Eur Respir Rev 2009; 18: 162-169 Year: 2009
Pulmonary functions in systemic sclerosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012
Lung function and pulmonary hypertension in systemic sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006
Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening Source: Eur Respir Rev 2011; 20: 270-276 Year: 2011
Pulmonary involvement in systemic sclerosis Source: Eur Respir Monogr 2019; 86: 90-105 Year: 2019
Pulmonary function in progressive systemic sclerosis Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002
Stress-Doppler-Echocardiography for early detection of systemic sclerosis associated pulmonary arterial hypertension Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014
Identifying early pulmonary arterial hypertension in patients with systemic sclerosis Source: Eur Respir J, 51 (4) 1800495; 10.1183/13993003.00495-2018 Year: 2018
Response to PAH specific therapy in systemic sclerosis patients with extensive parenchymal changes and pulmonary hypertension Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020
Hemodynamic phenotypes in systemic sclerosis patients screened for pulmonary hypertension – impact of the new PH-definition Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside Year: 2019
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy Source: Eur Respir J 2009; 33: 371-379 Year: 2009
Clinical feature of systemic sclerosis associated with pulmonary hypertension: results of one center study Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008
Metabolic profiling of pulmonary vascular phenotypes in systemic sclerosis Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020
Pulmonary hypertension in systemic scleroderma Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003
Vasodilator testing in pulmonary arterial hypertension associated with systemic sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006
Idiopathic and systemic sclerosis-associated PAH: A comprehensive haemodynamic and radiological comparison Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016
Risk assessment in patients with systemic sclerosis and pulmonary arterial hypertension Source: Eur Respir J, 52 (4) 1801745; 10.1183/13993003.01745-2018 Year: 2018
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis Source: Eur Respir J, 51 (4) 1701197; 10.1183/13993003.01197-2017 Year: 2018
Pulmonary arterial hypertension: an autoimmune disease? Source: Eur Respir J 2005; 26: 986-988 Year: 2005